Unity Biotechnology Receives New Financing

  • Feed Type
  • Date
    2/4/2016
  • Company Name
    Unity Biotechnology
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158 USA
  • Company Description
    At UNITY, we design therapeutics that prevent, halt, or reverse numerous diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
  • Website
    http://www.unitybiotechnology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Unity will initially focus on cellular senescence, a biological mechanism theorized to be a key driver of many age-related diseases, including osteoarthritis, glaucoma and atherosclerosis.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Venrock
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Mayo Medical Ventures

Trending on Xconomy